Stock Analiz

Tonix Pharmaceuticals Holding Corp. (TNXP) stock forecast and price target

Price $3.01 · data as of November 13, 2026

12-month price target

Average target$34.00
Upside / downside+1029.6%
Analysts5
ConsensusStrong buy
Low $18.00Average $34.00High $64.00

Gold marker: average target · white marker: today’s price ($3.01)

Analyst ratings

Strong buy 0Buy 4Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-10.91+25.6%$58M
Next fiscal year
ends December 31, 2027
$-7.00+35.8%$113M
Next quarter
ends December 31, 2026
$-2.24+43.7%$20M
Quarter after
ends December 31, 2026
$-2.35+41.0%$23M

Consensus of the analysts covering Tonix Pharmaceuticals Holding, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Tonix Pharmaceuticals Holding stock price target?

The average 12-month target from 5 analysts is $34.00, 1029.6% above the current price of $3.01 Targets range from $18.00 to $64.00.

Is Tonix Pharmaceuticals Holding a buy according to analysts?

The consensus rating is “Strong buy” (4 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Tonix Pharmaceuticals Holding expected to earn?

Analysts expect EPS of $-10.91 for the fiscal year ending December 31, 2026 and $-7.00 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.